Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

Phase 1 study in Staphylococcus aureus endocarditis

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Phaxiam Therapeutics

Enrolment target

12

Start

03 Oct 2023

Infectious S. aureus endocarditis

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
France

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.